BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19079593)

  • 1. Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: evidence of an oxidant-sensitive pathway.
    Desideri G; Grassi D; Croce G; Bocale R; Tiberti S; Evangelista S; Necozione S; Di Orio F; Ferri C
    Mediators Inflamm; 2008; 2008():305087. PubMed ID: 19079593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets.
    Lupi R; Del Guerra S; Bugliani M; Boggi U; Mosca F; Torri S; Del Prato S; Marchetti P
    Eur J Endocrinol; 2006 Feb; 154(2):355-61. PubMed ID: 16452552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
    Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
    Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ACE inhibition on spontaneous and insulin-stimulated endothelin-1 secretion: in vitro and in vivo studies.
    Desideri G; Ferri C; Bellini C; De Mattia G; Santucci A
    Diabetes; 1997 Jan; 46(1):81-6. PubMed ID: 8971086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis.
    Marampon F; Gravina GL; Scarsella L; Festuccia C; Lovat F; Ciccarelli C; Zani BM; Polidoro L; Grassi D; Desideri G; Evangelista S; Ferri C
    J Hypertens; 2013 Oct; 31(10):1972-83. PubMed ID: 23868084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The haemodynamic effects of two angiotensin converting enzyme inhibitors, enalaprilat and zofenoprilat, in the rat: evidence for the involvement of bradykinin.
    Tio RA; Heiligers JP; de Langen CD; van Gilst WH; König W; Saxena PR; Wesseling H
    J Hypertens Suppl; 1989 Dec; 7(6):S296-7. PubMed ID: 2561143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XJP-1, a novel ACEI, with anti-inflammatory properties in HUVECs.
    Fu R; Chen Z; Wang Q; Guo Q; Xu J; Wu X
    Atherosclerosis; 2011 Nov; 219(1):40-8. PubMed ID: 21803355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species.
    Cominacini L; Pasini A; Garbin U; Evangelista S; Crea AE; Tagliacozzi D; Nava C; Davoli A; LoCascio V
    Am J Hypertens; 2002 Oct; 15(10 Pt 1):891-5. PubMed ID: 12372676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Captopril inhibits endothelin-1 secretion from endothelial cells through bradykinin.
    Momose N; Fukuo K; Morimoto S; Ogihara T
    Hypertension; 1993 Jun; 21(6 Pt 2):921-4. PubMed ID: 8389325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands.
    Ignjatovic T; Stanisavljevic S; Brovkovych V; Skidgel RA; Erdös EG
    Mol Pharmacol; 2004 Nov; 66(5):1310-6. PubMed ID: 15304551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors attenuate propofol-induced pro-oxidative and antifibrinolytic effect in human endothelial cells.
    Wojewodzka-Zelezniakowicz M; Gromotowicz-Poplawska A; Kisiel W; Konarzewska E; Szemraj J; Ladny JR; Chabielska E
    J Renin Angiotensin Aldosterone Syst; 2017 Jan; 18(1):1470320316687197. PubMed ID: 28090801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial antioxidant actions of dihydropyridines and angiotensin converting enzyme inhibitors.
    Rosenkranz AC; Lob H; Breitenbach T; Berkels R; Roesen R
    Eur J Pharmacol; 2006 Jan; 529(1-3):55-62. PubMed ID: 16313901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant and nitric oxide-sparing actions of dihydropyridines and ACE inhibitors differ in human endothelial cells.
    Lob H; Rosenkranz AC; Breitenbach T; Berkels R; Drummond G; Roesen R
    Pharmacology; 2006; 76(1):8-18. PubMed ID: 16220025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events.
    Enseleit F; Hürlimann D; Lüscher TF
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S21-30. PubMed ID: 11392475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption.
    Zhang X; Xie YW; Nasjletti A; Xu X; Wolin MS; Hintze TH
    Circulation; 1997 Jan; 95(1):176-82. PubMed ID: 8994434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk.
    Donnini S; Terzuoli E; Ziche M; Morbidelli L
    J Pharmacol Exp Ther; 2010 Mar; 332(3):776-84. PubMed ID: 19959747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sesamin induces nitric oxide and decreases endothelin-1 production in HUVECs: possible implications for its antihypertensive effect.
    Lee CC; Chen PR; Lin S; Tsai SC; Wang BW; Chen WW; Tsai CE; Shyu KG
    J Hypertens; 2004 Dec; 22(12):2329-38. PubMed ID: 15614027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide release from rat aortic smooth muscle cells is not attenuated by angiotensin converting enzyme inhibitors.
    Ikeda U; Shimada K
    Eur J Pharmacol; 1994 Nov; 269(3):319-23. PubMed ID: 7534708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinin- and angiotensin-converting enzyme (ACE) inhibitor-mediated nitric oxide production in endothelial cells.
    Skidgel RA; Stanisavljevic S; Erdös EG
    Biol Chem; 2006 Feb; 387(2):159-65. PubMed ID: 16497147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.